EUCTR2010-018531-17-GB进行中（未招募）不适用
Effect of Tredaptive on serum lipoproteins, lipoproteins metabolism, oxidative stress and HDL antioxidant function. - Effect of Tredaptive on serum lipoproteins and inflammatory markers
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Men and women who are taking cholesterol-lowering medication (maximum tolerated statins and/or ezetimibe) and who have not reached the recommended LDL target of less than 1.8 mmol/l (70 mg/l). Ezetimibe will be stopped 4 weeks before entering the study.
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- •Pregnant and/or breast-feeding women.
- •Significant renal impairment (eGFR < 59ml/min).
- •Active liver disease and transaminases > 3 times upper limit of normal range.
- •Patients on fibrates.
- •Patients on Omacor.
- •Patients who are allergic to nicotinic acid.
研究者
相似试验
已完成
4 期
Effect of Tredaptive on Serum Lipoproteins and Inflammatory MarkersHypercholesterolemiaNCT01054508Manchester University NHS Foundation Trust38
招募中
不适用
Effects of Low Density Lipoprotein adsorption treatment on Arteriosclerosis obliterates(ASO)JPRN-UMIN000014762Division of Nephrology, Department of Internal Medicine , WAKAYAMA MEDICAL UNIVERSITY30
尚未招募
不适用
Influence of a Lipoprotein(a)-Lowering Therapy on Insulin SensitivityE78.5Hyperlipidaemia, unspecifiedDRKS00031748Charité Universitätsmedizin Berlin13
已完成
不适用
Study of reducing of serum LDL-cholesterol levels by ingestion of test supplement -A randomized, double blinded, placebo controlled, parallel group comparison studyHealthy subjectsJPRN-UMIN000043559FANCL Corporation90
已完成
2 期
MARS - Monitored Atherosclerosis Regression StudyAtherosclerosisCoronary Artery DiseaseNCT00116870Merck Sharp & Dohme LLC270